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ABSTRACT: 
Restoration of the Chol homeostasis in the Central Nervous System (CNS) could be beneficial for the 
treatment of Huntington’s Disease (HD), a progressive, fatal, adult-onset, neurodegenerative disorder. 
Unfortunately, Chol is unable to cross the blood-brain barrier (BBB), thus a novel strategy for a targeted 
delivery of Chol into the brain is highly desired.  
This article aims to investigate the production of hybrid nanoparticles composed by Chol and PLGA (MIX-
NPs) modified with g7 ligand for BBB crossing.  
We described the impact of ratio between components (Chol and PLGA) and formulation process 
(nanoprecipitation or single emulsion process) on physico-chemical and structural characteristics, we 
tested MIX-NPs in vitro using primary hippocampal cell cultures evaluating possible toxicity, uptake, and 
the ability to influence excitatory synaptic receptors.  Our results elucidated that both formulation 
processes produce MIX-NPs with a Chol content higher that 40%, meaning that Chol is a structural particle 
component and active compound at the same time. The formulation strategy impacted the architecture 
and reorganization of components leading to some differences in Chol availability between the two types 
of g7 MIX-NPs. Our results identified that both kinds of MIX-NPs are efficiently taken up by neurons, able to 
escape lysosomes and release Chol into the cells resulting in an efficient modification in expression of 
synaptic receptors that could be beneficial in HD. 
 
1) Introduction: 
Efficient delivery of cholesterol (Chol) has recently received considerable attention for its chances to 
succeed in the treatment of Huntington disease (HD) (Valenza et al., 2010; Zuccato et al., 2010). HD is an 
adult-onset, neurodegenerative disorder characterized by cell loss mainly in the striatum and cortex, and 
caused by an abnormal repetition of three DNA bases (Cytosine, Adenine and Guanine) in the gene 
encoding the huntingtin protein (htt). Among others, mutant htt has effects on sterol regulatory element 
binding proteins, which results in lower Chol levels in affected areas of the brain (Block et al., 2010).  
The brain Chol is completely from endogenous source (local syntheses) being peripheral Chol unable to 
pass the blood-brain barrier (BBB) (Dietschy and Turley, 2004). Thus, the reduction of Chol biosynthesis in 
HD brain is detrimental for neuronal function altering both the structure and integrity, remodeling 
synapses, and consequently, synaptic transmission (Leoni et al., 2013; Valenza et al., 2007). The re-
establishment of adequate Chol level in the brain appears as a promising approach in the treatment of HD 
where currently no effective therapies exist (Zuccato et al., 2010).  
A number of strategies were developed to overcome BBB and to improve delivery of therapeutic agents to 
the brain. These approaches ranged from temporarily disrupting the barrier itself or modifying transported 
agents by chemical linkage to ligands able to enhance BBB drug permeability up to to deliver drugs directly 
into the brain through a variety of strategies which effectively bypass the BBB entirely (Gao 2016). More 
recently, to improve drug delivery to the brain, non-invasive techniques based on the use of nanocarriers 
able to loading drugs and modified on surface by conjugating antibodies or ligands received considerable 
attention (Hersh et al., 2016; Saraiva et al., 2016).  
Recent in vivo and in vitro studies demonstrated that nanoparticles (NPs) based on FDA approved poly (D,L-
lactide-co-glycolide) polymer (PLGA) and surface modified with a g7-glycopeptide (g7-NPs) are able to cross 
the BBB in a non-invasive way. This g7-glicopeptide conjugated onto NPs surface stimulates membrane 
curvatures and following endocytosis process of the whole system at BBB level, promoting the BBB crossing 
by multiple pathways (Tosi et al., 2011 a). Moreover, when loaded with drug (g7-NPs/Chol) are able to 
deliver  Chol into the brain. Importantly, repeated systemic administration of g7-NPs/Chol rescued synaptic 
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communication, protected from cognitive decline and partially improved global activity in HD mice (Valenza 
et al., 2015). These results highlight the potential of g7-NPs/Chol in restoring brain Chol homeostasis with 
overall beneficial effects on HD pathology. Aiming at clinical translation some drawbacks must be 
overcome, especially the low drug-content (less than 1%), which force to repeated administrations and 
systemic accumulation of synthetic polymers. To overcome these possible limitations, we investigated a 
different approach, specifically designed to enable delivery of the therapeutic dose of Chol into the brain by 
a low number of administrations for a better patient-compliance. 
 
 
This study aims to describe the formulation of new hybrid nanoparticles (named MIX NPs) based on a 
specific combination of polymer (g7-PLGA and PLGA) and Chol as formulative components. Hybrid 
nanoparticles were obtained applying nanoprecipitation (MIX-N) or single-emulsion (MIX-SE) techniques. 
Our study emphasizes the relationship between the nanoparticle composition and the formulation process 
with respect to the size, Chol content and nanoparticle stability. After the technological characterization 
both MIX-N and MIX-SE were tested in vitro on primary neuronal cells to investigate the tropism for brain 
cells and the toxicity. 
 
 
 
Materials and Methods 
2) Materials: 
Poly(D,L-lactide-co-glycolide) (PLGA) (RG503H; 50:50 mol:mol, inherent viscosity 0.38 dL/g) was used as 
polymer (Boehringer-Ingelheim, Ingelheim am Rhein, Germany). According to the experimental titration 
results of the carboxylic end of the polymers, the MW of RG503H was calculated to be 11,000. Gly-l-Phe-d-
Thr-Gly-l-Phe-l-Leu-l-Ser(O-β-d-glucose)-CONH2 (g7) was prepared as described previously and conjugated 
with PLGA to obtain g7-PLGA (Tosi et al., 2007). The PLGA derivatization - yields (30-40 μmol peptide/g of 
polymer) were estimated by NMR from the relative peak area of the signals at 7.2-7.5 ppm, corresponding 
to the aromatic protons of the Phe present, and of the multiplet at 1.80–1.60 ppm corresponding to the 
protons of the methyl groups of the polymer. Rhod-PLGA was synthesized conjugating PLGA with 
Rhodamine B piperazine amide (Sigma-Aldrich, Milan, Italy) (Tosi et al., 2007). Cholesterol (Chol), Pluronic-
F68, and poly vinyl alcohol (PVA; 13-15000 Da, degree of hydrolysation 86–89 Mol%, viscosity at 4% w/v in 
water 3.5-4.5 cps) were purchased from Sigma Aldrich as well as the solvents (HPLC grade) used for 
analyses. Dulbecco’s Modified Eagle Medium (DMEM), heat inactivated fetal bovine serum (FBS), and 
Dulbecco's Phosphate Buffered Saline (PBS) were purchased from Euroclone Celbio (Milan, Italy). 
Antibodies against MAP2 and GFAP were purchased from Novus Biological (Littleton, CO, USA) and Abcam 
(Cambridge, UK), respectively. Secondary antibodies Alexa and LysoTracker were obtained from Invitrogen 
(Life technologies, Darmstadt, Germany) and apoptosis/necrosis/healthy cell detection kit (Promokine) 
from PromoCell (Heidelberg, Germany). A MilliQ water system (Millipore, Bedford, MA, USA), supplied with 
distilled water, provided high-purity water (>18 MΩ). Unless otherwise indicated, all other chemicals were 
of analytical grade (Sigma Aldrich) and used without further purification.  
 
3) Methods: 
  
 
4 
 
 
3.1 Preparation of nanoparticles  
Nanoparticles composed by Chol and PLGA (MIX-NPs) were prepared by nanoprecipitation method (MIX-N) 
and by single emulsion technique (MIX-SE) using 50 mg of mixtures at different Chol:PLGA (w/w) ratio, i.e 
1:1 (MIX _a), 1:0.4 (MIX _b), 1:0.25 (MIX _c) and 1:0.1 (MIX _d) (see supplementary table S1).  
3.1.1 Nanoparticles obtained by the nanoprecipitation method (MIX-N) 
To obtain MIX-N, the different Chol:PLGA mixtures were dissolved in acetone (4 mL). The organic phase was 
then added dropwise into 50 mL of a 0.5% (w/v) Pluronic-F68 aqueous solution at 45°C under magnetic 
stirring (1,300 rpm). After 10 min, the organic solvent was removed at 30°C under reduced pressure (10 
mm Hg). The MIX-NPs were recovered and purified twice by an ultracentrifugation process carried out at 
17,000 rpm for 10 min (4°C; Sorvall RC28S, Dupont, Brussels, Belgium) to remove the unformed material 
and the free surfactant fraction in the solution. The obtained MIX-N (MIX-N_a, MIX-N_b, MIX-N _c and MIX-
N_d) were re-suspended in water (5 mL), stored at 4°C and used within a week. 
NP-N (PLGA nanoparticles), were prepared as reference following the same procedure above described but 
using only PLGA (50 mg). 
3.1.2. Nanoparticles obtained by the single emulsion method (MIX-SE) 
In the single emulsion technique, the different Chol:PLGA mixtures were dissolved in dichloromethane (4 
mL) and emulsified in 20 mL of 1% (w/v) PVA aqueous solution by sonication (Microson Ultrasonic cell 
disruptor, Misonix Inc. Farmingdale, NY, USA) (80W over 1 min) under cooling (5°C). Then, the O/W 
emulsion was stirred for at least 3 h (1,300 rpm; RW20DZM, IKALabortechnik, Staufen, Germany) at r.t. to 
allow the solvent evaporation. The MIX-SE (MIX-SE_a, MIX SE_b, MIX-SE_c and MIX-SE_d) were collected 
and purified by ultracentrifugation as previously described for MIX-N, and stored at 4°C before the use. 
 
NP-SE (PLGA nanoparticles) were prepared as reference following the same procedure described for MIX-SE 
but using only PLGA (50 mg). 
 
3.1.3. Nanoparticles preparation for the in vitro studies  
g7-MIX NPs (g7-MIX-N_a and g7-MIX-SE _a) used for the in vitro experiments were obtained as above 
reported but using a mixture of Chol (50%), PLGA (45%), and g7-PLGA (5%). Labelled g7-(Rhod)-MIX NPs 
(g7-(Rhod)-MIX-N_a and g7-(Rhod)-MIX-SE_a) were prepared as reported above but using a mixture of Chol 
(50%), PLGA (42.5%), g7-PLGA (5%), and Rhod-PLGA (2.5%) (supplementary table S1). 
 
3.2 Evaluation of yield  
The recovered MIX-N or MIX-SE suspension was freeze-dried (-60°C, 1.10-3 mm/Hg for 48 h; LyoLab 3000, 
Heto-Holten, Allerod, Denmark) and the yield (Yield%) was calculate as follows: 
Yield (%) = [(mg of freeze dried MIX-N or MIX-SE)/(mg PLGA+ mg Chol)] x 100 
 
3.3 Physico-chemical characterization of nanoparticles 
Mean particle size (Z-Average) and polydispersivity index (PDI) of the samples were determined using a 
Zetasizer Nano ZS (Malvern, UK; Laser 4 mW He–Ne, 633 nm, Laser attenuator Automatic, transmission 
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100–0.0003%, Detector Avalanche photodiode, Q.E. > 50% at 633 nm). Samples were diluted in PBS pH 7.4 
at about 0.5 mg/mL. The results were also expressed as intensity distribution, i.e. the size 10% [D(10)], 50% 
[D(50)] and 90% [D(90)], below which all the MIX NPs are placed. The zeta potential (ζ-pot l) was measured 
using the same equipment with a combination of laser Doppler velocimetry and phase analysis light 
scattering (PALS). All data are expressed as means of at least three determinations carried out for each 
prepared lot (three lots for each sample). 
 
The morphology of the samples was evaluated by atomic force microscopy (AFM) (Park Instruments, 
Sunnyvale, CA, USA) at about 20°C operating in air and in non-contact mode using a commercial silicon tip-
cantilever (high resolution noncontact “GOLDEN” Silicon Cantilevers NSG-11, NT-MDT, tip radius 10 nm; 
Zelenograd, Moscow, Russia) with stiffness of about 40 Nm−1 and a resonance frequency around 160 kHz. A 
drop of each MIX-NPs suspension was diluted with distilled water (about 1:5 v/v) before application on a 
small mica disk (1 cm× 1 cm). After 2 min, the excess of distilled water was removed using a paper filter and 
the sample analyzed. Two kinds of images were obtained: the first is a topographical image and the second 
is indicated as “error signal”. This error signal is obtained by comparing two signals: the first one 
representing the amplitude of the vibrations of the cantilever, and the second the amplitude of a reference 
point. The images obtained by this method show small superficial variations of the samples. Images were 
processed and analyzed using software from Gwyddion (Department of Nanometrology, Czech Metrology 
Institute, Brno, Czech Republic). 
 
The internal structure/architecture of the samples was analyzed by scanning transmission electron 
microscopy (STEM). Briefly, a drop of a water-diluted suspension of the samples (about 0.03 mg/mL) was 
placed on a 200-mesh copper grid (TABB Laboratories Equipment, Berks, UK), allowed to adsorb, and the 
suspension surplus was removed by filter paper. All grids were analyzed using a Nova NanoSEM 450 (FEI, 
Oregon, USA) transmission electron microscope operating at 30 kV using a STEM II detector in Field free 
mode.  
 
3.4 Residual of surfactant 
The residual amount of surfactants (Pluronic-F68 or PVA) was determined by a colorimetric method based 
on the formation of the colored complex between two adjacent hydroxyl groups of surfactant and an 
iodine molecule(Joshi et al., 1979). Briefly, 1 mg of a freeze-dried MIX NPs sample was solubilized in 0.5 mL 
of dicloromethane. Then, 10 mL of distilled water were added and the organic solvent was evaporated at 
r.t. under stirring for 2 h. The suspension was filtered (cellulose acetate filter, porosity 0.45 µm, Sartorius, 
Florence, Italy) to obtain an aqueous solution (A). 
To detect the Pluronic-F68 residual, 2 mL of the aqueous solution (A) were treated with 2 mL of 0.5% (w/v) 
BaCl2 in HCl 1N and 0.5 mL of an aqueous solution of I2/KI (0.05 M/0.15 M). The obtained solution was 
incubated at r.t. for 10 min in dark. Pluronic-F68 concentration was determined measuring the absorbance 
at 540 nm (Model V530, Jasco, Cremella, Italy) in comparison to a standard plot of Pluronic-F68 prepared 
under the same experimental conditions. Linearity was assumed in the range of 2-18 µg/mL (r2=0.995). All 
data are expressed as the mean of at least three determinations. 
To quantify the PVA residual, the aqueous solution (A) (1 mL) was treated with 0.5 M NaOH (2 mL) for 15 
min at 60°C. The solution was neutralized with 1 N HCl (900 μL) and the volume adjusted to 5 mL with 
water. Then, a solution of I2/KI (0.5 mL) (0.05 M/0.15 M) and water (1.5 mL) was added to 3 mL of a water 
solution of boric acid (0.65 M). PVA concentration was determined measuring the absorbance at 690 nm 
(Model V530, Jasco) after 15 min of incubation at r.t. in comparison to a standard plot of PVA prepared 
  
 
6 
 
under the same experimental conditions. Linearity was assumed in the range of 2-150 µg/mL (r2=0.998). All 
data are expressed as the mean of at least three determinations. 
 
3.5 Cholesterol content 
To quantify the amount of Chol into MIX NPs, an exact amount of MIX NPs (1 mg) was dissolved in 0.5 mL of 
chloroform, followed by addition of 1 mL of isopropyl alcohol to precipitate the polymer. The mixture was 
vortexed (15 Hz for 1 min; ZX3, VelpScientifica, Usmate, Italy) and then filtered (polytetrafluoroethylene 
filter, porosity 0.20 μm, Sartorius). The amount of Chol in the sample was quantified by RP-HPLC using an 
HPLC apparatus comprised a Model PU980 pump provided with an injection valve with a 50 µL sample loop 
(Model 7725i Jasco) and an UV detector (UV975, Jasco). Chromatography separation was carried out on a 
Syncronics C18 (250x4.6 mm; porosity 5 µm; Thermo Fisher Scientific, Waltham, MA, USA) at r.t. and with a 
flow rate of 1.2 mL/min, operating in an isocratic mode using 50:50 v/v acetonitrile:ethanol as mobile 
phase. The solvents of the mobile phase were filtered through 0.45 µm hydrophilic polypropylene 
membrane filters (Sartorius) before their use. Chromatographic peak-areas of the standard solutions were 
collected and used for the generation of calibration curves. Linearity was assumed in the range of 18-300 
µg/mL (r2=0.995). All data are expressed as the mean of at least three determinations. 
 
 
 
 
3.6 Differential scanning calorimetry (DSC) studies 
Thermal analysis was performed to evaluate the potential interaction between PLGA and Chol using a DSC 
200 PC (Netzsch, Selb, Germany). Briefly, about 4 mg of the samples [MIX NPs, physical mixtures PLGA:Chol,  
plain PLGA and plain Chol] were put in crimped aluminum pans (Netzsch) and heated at the rate of 5°C/min 
using dry nitrogen flow (20 mL/min). As the final temperature (190°C) was reached, the system was cooled 
by liquid nitrogen to 10°C and a second heating cycle started (5°C/min from 20 to 190°C). Indium (99.99%; 
Perkin Elmer, Norwalk, USA) (melting point 156.6 ◦C; ΔHf 28.45 J g
−1) was used to check the instrument. All 
DSC analyses were run in triplicate. Tonset is chosen to identify transition temperature while the enthalpy of 
process represents the total area of peak between Ti (initial temperature) and Tf (final temperature) 
calculated from the instrument software. 
 
3.7 In vitro experiments 
 
3.7.1 Cell culture 
Hippocampal cultures were prepared from rat (embryonic day 18) as before described (Grabrucker et al., 
2009). In brief, after preparation of hippocampi from rat embryos, dissociated hippocampal neurons were 
seeded on poly-l-lysine (0.1 mg/ml; Sigma-Aldrich) coated 10 cm petri dishes at a density of 3 x 106 
cells/dish or 24 well plates with a density of 3 x 104 cells/well. Cells were grown in NeurobasalTM medium 
(Life Technologies), complemented with 2% B27 supplement (Life Technologies), 2 mM L-Glutamine (Life 
Technologies) and 1% penicillin/streptomycin (Life Technologies) and maintained at 37°C in 5% CO2. All 
experiments were performed in compliance with the guidelines for the welfare of experimental animals 
issued by the Federal Government of Germany and by the local ethics committee of Ulm University (ID 
Number: O.103). 
 
3.7.2 Treatment of primary neuronal cultures with MIX NPs 
Eleven days after seeding (11 DIV), culture medium was replaced with fresh medium containing MIXs NPs 
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(nanoparticles were diluted just before the treatment). After 6 h, the medium containing MIXs NPs was 
removed and cells were analyzed or incubated in fresh medium devoid of MIX NPs until 24 h. Treatments 
were performed maintaining a constant amount of Chol, which is the active part of the structure. In more 
detail, 200 µg of Chol (corresponding to 0.45 mg of g7-MIX-N_a or g7-(Rhod)-MIX-N_a and 0.36 mg of g7-
MIX-SE_a or g7-(Rhod)-MIX-SE_a) were used to treat 300,000 cells. The selected concentration of Chol was 
not toxic as previously reported (Belletti et al., 2016).  
 
3.7.3 Immunocytochemistry 
For immunofluorescence, hippocampal neurons were fixed with 4% paraformaldehyde (PFA) / 4% sucrose / 
PBS at 4°C for 20 min. After washing 3x 5 min with 1x PBS containing 0.2% Triton X-100 at r.t., blocking was 
performed with 10% FBS/ 1x PBS for 1 h at r.t. Subsequently, the samples were incubated with the primary 
antibody at r.t. for 2 h. After a 3x5 min washing-step with 1x PBS, incubation with the secondary antibody 
coupled to Alexa488, Alexa568 or Alexa647 followed for 1 h. Cell nuclei were counterstained with DAPI and 
coverslips subsequently mounted using Vecta Mount (Vector Laboratories, Burlingame, CA, USA). 
Fluorescence images were obtained with an upright Axioscope microscope equipped with a Zeiss CCD 
camera (16 bits; 1280x1024 ppi) using Axiovision software (Zeiss, Jena, Germany). Quantification was 
performed using ImageJ Freeware version V 1.51a downloaded from the NIH website 
(http://rsb.info.nih.gov/ij). 
 
 
3.7.4 Determination of cell health  
In order to determine cell death (apoptosis versus necrosis), primary hippocampal neurons from rat were 
seeded on a 24 well plate, and apoptosis and necrosis were assessed using the apoptotic/necrotic/healthy 
cells detection kit according to the manufacturer guidelines. Treatment with 70% EtOH was used as positive 
control. 
 
3.7.5 Protein Biochemistry 
To obtain homogenate from treated neuronal cultures, cells were lysed and homogenized in lysis buffer 
(150 mM NaCl, 1% Triton X- 100, 50 mM Tris–HCl, pH 8.0) containing protease inhibitor (Roche, Mannheim, 
Germany). Cell debris and nuclei were removed by centrifugation at 3,200 rpm for 10 min resulting in 
supernatant S1 (soluble fraction) and pellet P1 (membrane associated fraction). Subcellular fractions were 
isolated as described previously with minor modifications(Schmeisser et al., 2012). Protein concentration 
was determined by Bradford protein assay. Proteins were separated by SDS-PAGE and blotted onto 
nitrocellulose membranes (GE Healthcare, Freiburg, Germany). Immunoreactivity was visualized using HRP-
conjugated secondary antibodies and the SuperSignal detection system (Pierce, Upland, USA). Quantitative 
evaluation of bands was performed using ImageJ. Three independent experiments were performed. The 
individual bands were selected and the integrated density was measured. Bands were normalized to β-actin 
and the ratios averaged and tested for significance.  
 
3.7.6 Statistics 
Statistical analysis was performed with SPSS version 20. All data are shown as mean ± SEM. For 
comparisons, one-way analysis of variance (ANOVA) was performed followed by post hoc tests for within 
group comparisons (Bonferroni test). Statistically significant differences are indicated in the figures or text 
by * p ≤ 0.05, ** p ≤ 0.01 and *** p ≤ 0.001. 
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4. RESULTS 
4.1 Nanoparticle formulation 
 
Z-Average (nm), polydispersivity index (PDI), ζ-pot (mV), yield, residual surfactant and % of Chol and PLGA 
forming MIX-N and MIX-SE are shown in Table 1.  
Dimension of MIX-NPs formed by nanoprecipitation (MIX-N) suffers from some initial composition of the 
mixture, with both mean diameter and polidispersity increased along with the amount of Chol used in the 
formulation. MIX-N_a, prepared with a mixture of Chol:PLGA 1:1 (w:w), showed a mean diameter (Z-
Average) of about 220 nm, a D(90) of 678 nm and a PDI value of 0.26. The increase of Chol amount in the 
initial mixture (MIX-N_b; Chol:PLGA 1:0.4 w:w) produced a significant (p<0.05) increase of Z-Average (up to 
320 nm), D90 (920 nm) and PDI (0.31). The hypothesis of an increasing trend in the size is sustained by the 
dimensions of MIX-N with a higher Chol ratio. In fact, the Z-Average increased up to 361 nm (PDI= 0.36) in 
MIX-N_d where the weight polymer ratio is strongly increased in favor of Chol with respect to PLGA 
(Chol:PLGA 1:0.1). As far as the nanoparticle composition, by use more Chol in the mixture of production, 
the final structure resulted enrich in sterol, however the amount of PLGA and Chol really present in the 
MIX-N do not correspond to the nominally ratio used in the NP preparation. Briefly, MIX-N_a (Chol:PLGA 
1:1 w:w) resulted in a polymeric-based structures composed by about 38% of Chol, 50% of PLGA and 12% 
of residual surfactant while Chol:PLGA 1:0.4 w:w sample (MIX-N_b) were almost lipidic-based NPs showing 
a significant increase (p<0.05) of the Chol content (65%) and a decrease of PLGA (22%) along with a 
constant surfactant residual (13%). MIX-N_d (Chol:PLGA 1:0.1 w:w) can be considered lipidic nanoparticles, 
composed by more than 80% of Chol, an amount of PLGA lower than 10% and a surfactant residue of 12%. 
The Chol-PLGA ratio used impact also the final yield, resulting in about 50% in both MIX-N_a and MIX-N_b 
and progressively decreased with the decreasing of the PLGA amount, reaching about a 40% value in MIX-
N_d (Chol:PLGA 1:0.1 w:w). 
The same mixtures of Chol and PLGA were used in the single emulsion procedure (MIX-SE) where PVA 
replaces Pluronic-F68 as surfactant. Most of the chemical physical characteristics analyzed were not 
affected by the ratio of PLGA and Chol used: all the samples showed a monomodal and monodisperse 
population with a Z-Average of about 290 nm (PDI about 0.2). The final composition was independent from 
that of the initial mixture composition. Both MIX-SE_a and MIX-SE_b were characterized by a more 
constant Chol:PLGA ratio (about 1:1; 40-45% w/w of Chol and 45-50% w/w of PLGA), i.e. the MIX NPs 
composition did not change as the initial Chol:PLGA ratio  was modified. The PVA residue was about 6% in 
MIX-SE_a and about 15% in the other MIX-SE (MIX-SE_b, MIX-SE_c, MIX-SE_d) prepared using the higher 
amount of Chol. The only parameter affected by the nominal ratio of PLGA was the final yield of MIX-SE 
which was 65% in MIX- SE_a and reaching 15% in MIX- SE_d (formed by the highest Chol:PLGA ratio).  
For both MIX-N and MIX-SE series, the negative ζ-pot value (ranging from about −30 and – 15 mV) was due 
to the exposition of oxydrilic and carboxyilic free groups on the surface of PLGA and Chol molecules.   
 
Sample Method Chol:PLGA 
weight 
ratio 
(theoretical)  
Z-
Aver.
(±SD) 
[nm] 
PDI     
(±SD) 
Di(50) 
(±SD) 
[nm] 
Di(90) 
(±SD) 
[nm] 
ζ-pot 
(±SD) 
[mV] 
Yield 
(%) 
Content 
of  Chol 
(%) 
Content 
of  PLGA 
(%) 
Content 
of  
surfactan
t (%) 
Chol:PLGA 
weight ratio 
 (experimental) 
NP_N 
N a n o p
r
ec ip it at io n
 
 
0:1 190 
(±11) 
0,1 
(±0,01) 
197 
(±10) 
250 
(±6) 
-27 
(±1) 
88 
 (±1) 
 91 
 (±3) 
9 
 (±4) 
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MIX-N_a 1:1 222     
(±14) 
0,26     
(±0,05) 
235  
(±9) 
678     
(±86) 
-24 
(±3) 
51 
(±1) 
38 
(±5) 
52 
(±2) 
10 
(±2) 
1:1.6 
MIX-N_b 1:0.4 321       
(±21) 
0,31        
(±0,07) 
325           
(±22) 
920       
(±162) 
-22 
(±4) 
49 
(±7) 
65 
(±3) 
22 
(±2) 
13 
(±2) 
1:0.3 
MIX-N_c 1:0.25 330         
(±27) 
0,32         
(±0,07) 
325          
(±30) 
1098         
(±712) 
-18         
(±2) 
50 
(±4) 
74 
(±4) 
11 
(±3) 
15 
(±3) 
1:0.15 
MIX-N_d 1:0.1 361 
(±22) 
0,36 
(±0,06) 
359 
(±24) 
2245 
(±88) 
-21 
(±3) 
41  
(±3) 
81 
(±1) 
7 
(±2) 
12 
(±3) 
1:0.09 
NP-SE 
Si
n
gl
e 
 E
m
u
ls
io
n
 
 
0:1 203 
(±11) 
0,12 
(±0,02) 
215 
(±10) 
340 
(±8) 
-24 
(±1) 
80 
 (±2) 
 94 
 (±2) 
6 
 (±5) 
 
MIX-SE_a 1:1 286   
(±16) 
0,19   
(±0,01) 
283       
(±10) 
494  
(±44) 
-25 
(±1) 
62 
(±2) 
44 
(±2) 
50 
(±2) 
6 
(±3) 
1:1.1 
MIX-SE_b 1:0.4 291                
(±4) 
0,22                 
(±0,03) 
307 
(±11) 
542                 
(±77) 
-19                 
(±3) 
47 
(±11) 
40 
(±7) 
46 
(±7) 
14 
(±4) 
1:0.9 
MIX-SE_c 1:0.25 283 
(±9) 
0,19 
 (±0,06) 
284 
(±11) 
481 
(±31) 
-21 
(±3) 
28 
(±7) 
41 
(±6) 
44 
(±7) 
15 
(±3) 
1:0.9 
MIX-SE_d 1:0.1 282 
(±12) 
0,13 
(±0,03) 
298 
(±12)  
529 
(±24) 
-13 
(±2) 
18  
(±4) 
39 
(±2) 
44 
(±4) 
17 
(±4) 
1:0.9 
 
Table 1: Physico-chemical characterization of MIX NPs: Z-Average, PDI (polidispersivity index) and Zeta 
potential (ζ-pot) of MIX NPs after the purification process are shown. Content of Chol, PLGA and surfactant 
refers to weight of component with respect to 100 mg of total formulation recovered after the purification 
process. 
 
4.2 Structural characterization: 
4.2.1 Morphology 
 
AFM and TEM were used to study only the morphology and structure of MIX-N_a, MIX-N_b, MIX-SE_a and 
MIX-SE_b (Fig. 1). 
MIX-N_a were spherical and well-defined nanoparticles. Under AFM observation, they collapsed on the 
mica surface becoming flat structures with heights (H) not correlate to the diameters (ratio between 
diameter and height frequently about 6.5). TEM analyses revealed alterations of electron density related to 
differences in thickness likely associated to the hybrid structure of the matrix (Egerton, 2005). 
Both microscopic techniques allow to pointed out the effect on the Chol:PLGA ratio on the MIX-N stability. 
Particularly, AFM showed the collapsed unformed materials on mica surface that embedded aggregates of 
MIX-N_b in which a high amount of Chol was recovered (65% of MIX-N_b vs 38% of MIX-N_a). In this 
sample, TEM confirmed the presence of large amounts of un-formed materials both as continuous film 
enveloping the nanoparticles and non-electron dense spherical lipidic discs. 
 
MIX-SE_a, notwithstanding some aggregations occurring after deposition on mica, is featured by well-
defined particle populations, showing a good correlation between diameters and heights (diameter/height 
ratio of about 3). TEM analyses confirmed the presence of spherical and electron dense structures.  
In contrast, MIX-SE_b were difficult to analyze with AFM as they showed high amounts of collapsed 
material that disrupts the tip approach. It is possible that the high amount of residual PVA in MIX-SE_b (14 
% vs 6% of MIX-SE_a), probably adsorbed on surface, rapidly desorbed during deposition and dehydration 
(when occurred), produces a layer upholstering the nanoparticle surface. MIX-SE_a aggregates were easily 
detected using TEM analyses.  
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Fig. 1. Microscopic characterization of MIX NPs samples. Each panel reports a combination of AFM and TEM of the sample; left: AFM images (error signal, 
thopographical images with the related analyses of profiles) are reported- right: STEM images and related magnification. 
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4.2.2 DSC analyses  
 
Fig. 2 shows the DSC curves of the components forming MIX NPs (PLGA, Chol, PVA, Pluronic-F68), of 
physical mixtures Chol:PLGA and of MIX-N_a, MIX-N_b, MIX-SE_a, and MIX-SE_b. All the samples 
underwent a heating run followed, after a cooling cycle, by a second heating run. The transition 
temperature (Tonset) and the enthalpy (ΔH, J/g) values associated with each transition were obtained 
through analysis of DSC-curves and are summarized in the supplementary Fig. S1. 
The first heating run of the plain Chol (Fig. 2 panel a1) showed the polymorphic transition at 38±1°C (Bach 
and Wachtel, 2003) (ΔH =7±1 J/g) followed by the sharp endothermic peak at 151±2°C of the melting of the 
crystalline phase of Chol. After cooling, in the second heating run (Fig. 2, panel a2), the polymorphic 
crystalline transition of Chol did not appear, while the melting point was clearly visible. Plain PLGA showed 
an endothermic transition at 47±2°C, which corresponds to the typical Tg of polymer (Fig. 2, panel a1). In 
the second heating run, the Tg value of PLGA was slightly shifted (to about 49.0°C) probably as a result of 
the loss of water molecules occurring during the first heating run (Fig. 2, panel a2). [15] Pluronic-F68 
showed the typical endothermic transition at 51±1°C, observed in both the first and second heating scan 
(Fig. 2, panel a2); PVA, a semi-crystalline polymer, showed an endothermic transition at 32±1°C, which 
corresponds to the typical Tg (Kapoor et al., 2015), that did not appear in the second heating cycle. 
The physical mixtures Chol:PLGA (Fig. 2, panel b) showed In the first heating cycle both the polymorphic 
crystalline transition and the melting point of Chol (38°C±1 and 151±2°C, respectively) that became less 
intense as the Chol:PLGA ratio decreased [(ΔH = 47 J/g in Chol-PLGA 1:0.1 (Fig. 2, panel b-1, line a) up to 3 
J/g in Chol:PLGA 0.1:1 (panel b-1, line f)] owing to the decreasing amount of Chol. The PLGA transition (Tg) 
was only detected for polymer concentration was higher than 40% (Chol:PLGA 1:0.4, panel b-1, line c). 
During the second heating cycle, the thermograms of the physical mixtures Chol:PLGA 1:0.1 and Chol:PLGA 
1:0.25 (Fig. 2, panel b-2, lines a and b) showed a faint endothermic transition in the range 30-50°C followed 
by the melting of Chol (151 ±2°C). Decreasing the Chol amount (Fig. 2, panel b-2, lines c to f) both 
transitions shifted towards a lower temperature. Enthalpy associated with the melting of Chol was reduced 
of about 30% in mixtures with 1:0.4 and 1:1 Chol:PLGA ratio and about 98% in Chol-PLGA 0.1:1 respect to 
the first heating cycle (Fig. 2, panel b-2) (see supplementary Fig S1).  
These findings support literature data (Bettinetti and Mura, 1994; Chiou and Riegelman, 1971) and 
demonstrate that under controlled condition Chol and PLGA can produce a solid dispersion (by fusion 
method) where Chol can probably be distributed in the crust of the polymer. 
 
The thermograms of MIX-N_a and MIX-N_b (Fig. 2, panel c) showed a large transition at about 50°C which 
changed during the second heating run in two peaks: the first at about 30°C could be associated to the 
polymorphic crystalline transition of Chol, and the second in the range of 46-49°C could be associated to 
Pluronic-F68. [11] The typical endothermic transition ascribable to the Chol melting occurred at 143±2°C in 
the first as well as the second heating cycle. The Chol enthalpy in the MIX-N_a and MIX-N_b agreed with 
the value estimated for the corresponding physical mixtures (about 20 J/g in MIX_N_a, and about 31 J/g in 
MIX-N_b). A small reduction in the enthalpy values (about 5%, Fig. 2, panel c-2 and supplementary Figure 
S1) was recorded in the second thermogram. Transitions related to PLGA were not clearly detectable in 
both the first and the second heating cycle. 
In MIXs-SE only a faint signal at about 48°C was observed in the first heating cycle. The melting of Chol (147 
± 0.5°C) was clearly visible (25 J/g; similar to the value measured in mixture Chol:PLGA 1:1 w/w, Fig. 2, line 
d, panel b), this transition shifted through low temperature (142 ± 2°C) in the second run. The reduction of 
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enthalpy (about 20% with respect to the first run) as to that of the corresponding physical mixture (line d, 
panel b), suggests a miscibility of Chol and PLGA in MIX-SE.  
 
 
 
Fig. 2: DSC curves. (a) plain components, (b) physical mixtures: Chol:PLGA 1:0.1w:w (line a), 
Chol:PLGA 1:0.25 (line b), Chol:PLGA 1:0.4 (line c), Chol:PLGA 1:1 (line d), Chol:PLGA 0.25:1 
(line e), Chol:PLGA 0.1:1 (line f);  (c) MIX Nps samples: MIX-N_a (line a); MIX-N_b (line b); 
MIX-SE_a (line c); MIX-SE_b (line d). All the samples underwent to two consecutive heating 
cycle: the first (a-1, b-1, c-1) reported in panel 1 (left) and the second (re-fusion) (a-2, b-2, c-
2) reported in panel 2 (right).  
 
4.2.3 Nanoparticles stability 
 
Stability of MIX-N and MIX-SE in PBS suspension stored at 4°C was monitored for 14 days by PCS analysis 
(change in diameter, monodispersion of samples, superficial charge) along with the possible loss of Chol, 
PLGA, and surfactant (Fig. 3). 
MIX-N_a was stable in terms of both dimension and composition during the storage time. On the contrary, 
MIX-N_b changed both their dimension and composition: a trend in reduction of Z-Average was measured 
notwithstanding both PDI and D90 increased during the experimental time (the value of D(90) shifts from 
503 to 708 nm, see supplementary data for size distribution, Fig. S2).  The amount of Chol in MIX-N_b was 
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reduced from 65±2% at the day 0 to 46±1% at the day 14. Chol, probably not well integrated into the 
structure, was lost inducing a change in Chol-PLGA reorganization which reflect the major heterogeneity in 
size of MIX_N_b. 
Both MIXs-SE_a and MIXs-SE_b showed a higher stability after the 14 days of storage as both physico-
chemical and composition data did not show remarkable modifications (Figure 3). 
For both kind of MIXs, samples prepared with a mixture Chol:PLGA 1:1 (MIX-N_a and MIX_ES_a) were also 
analyzed for their chemical stability after incubation in a complex medium composed by PBS and FBS (50%). 
The amount of Chol was mainly constant within 6 hours (see supplementary Table S2); minimum losses 
were detectable (less than 10% of total Chol), suggesting that Chol is stable enclosed into matrix structure 
and that its release during the circulation should happen at very low extent. 
 
 
 
Fig. 3: Physico-chemical characterization and composition of MIX NPs. MIX-N_a, MIX-N_b, MIX-
SE_a and MIX-SE_b during 14 days of storage.  
 
4.3 Biological studies on MIX-N_a and MIX- SE_a in vitro: 
As MIX-N_a and MIX- SE_a showed dimensions suitable for i.p. administration, stable reorganization of 
both Chol and PLGA, and suitable stability, they were selected for in vitro studies. To deliver Chol into the 
CNS, the surface of MIX NPs was modified with a g7 peptide able to induce the BBB crossing (Tosi et al., 
2007; Tosi et al., 2011b) (g7-MIX-N_a and g7-MIX-SE_a). Moreover, a rhodamine fluorescent label was 
bound to the surface to trace the MIX NPs in cells and tissues (g7-(Rhod)-MIX-N_a and g7-(Rhod)-MIX-
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SE_a). For physico-chemical characterization of g7-MIX-N_a, g7-MIX-SE_a, g7-(Rhod)-MIX-N_a, and g7-
(Rhod)-MIX-SE_a see supplementary data Table S3 and Fig. S3.  
 
4.3.1 Toxicity 
Apoptosis induced by g7-MIX-N_a and g7-MIX-SE_a in primary neuronal cultures after 24 h of treatment 
was evaluated quantifying the levels of cleaved casapse-3 and cleaved PARP (Fig. 4). Cells treated with 
nanoparticles showed significantly higher levels of cleaved caspase-3 (that provides a read-out for 
apoptotic processes initiated within a cell) compared to control cells. Another key protein involved in 
cellular apoptosis is the nuclear enzyme poly(ADP-ribose), PARP. In particular, in case of severe damage, 
PARP can be cleaved by enzymes such as caspases or cathepsins that inactivate the protein, promoting 
apoptosis (Virág et al., 2013). In both cell line, levels of cleaved PARP were not significanlty altered 
regardless the MIX-NPs tested. Since PARP is downstream of caspase-3, the increase in cleaved caspase-3 
might not be sufficient to trigger apoptotic events via PARP. 
These data were confirmed on cellular level using immunocytochemistry as read-out.  Neuronal cells were 
treated for 6–24 hours with g7-MIX-N_a and g7-MIX-SE_a, and the fraction of apoptotic cells was assessed 
and compared to untreated control cells (Fig. 4-c) showing that no major apoptotic processes are active 
upon application of g7-samples.  
  
Fig4: Toxicity of MIX NPs. A,B) Quantification of the ratio between (A) uncleaved and cleaved Caspase 3 
normalized to Actin and (B) between uncleaved and cleaved PARP normalized to Actin (n = 3 per condition). 
Exemplary WB bands are shown on the right. C) Evaluation of 10 optic fields of view per condition regarding 
the total number of cells (labeled by Hoechst33342 ) and percent apoptotic cells (labeled by FITC Annexin V).  
 
4.3.2 In vitro uptake 
 
To study both cellular uptake and localization, g7-(Rhod)-MIX-N_a and g7-(Rhod)-MIX-SE_a were applied to 
glial-neuronal co-cultures. MIX-NPs are visualized as red fluorescent puncta. We observed that both 
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samples (g7-(Rhod)-MIX-N_a and g7-(Rhod)-MIX-SE_a) were efficiently taken up by both neurons and glial 
cells. Already after 6 h of treatment, both neurons and glial cells showed uptake of MIX NPs in similar 
amount (Fig.5 panel a). 
To provide information about the mechanism of internalization we investigated the amount of 
nanoparticles co-localizing with caveolin (Fig. 5 panel b) or clathrin positive vesicles (Fig. 5 panel c) 6 and 24 
h after application. The results showed that, on average, only about 5% of MIX-NPs co-localize with 
caveolin positive signals, while about 60% of MIX-NPs co-localized with clathrin positive signals, without 
any difference between g7-(Rhod)-MIX-N_a and g7-(Rhod)-MIX-SE_a. This association with clathrin positive 
signals did not significantly change during time (6 h and 24 h after transfection). 
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Fig.5 Uptake of MIX NPs on hippocampal cells. A) Amount of MIX-NPs (red signal) co-localizing with GFAP, a 
marker for glial cells (green) and MAP2, a marker for neurons (magenta), assessed after 6 h and 24 h. Cell 
nuclei are visualized with DAPI (blue). The average number of MIX-NPs per cell (n = 10) is shown. B,C) 
Neurons were visualized by MAP2 staining and cell nuclei by DAPI. The amount of MIX-NPs (red signals) co-
localizing with anti-Caveolin positive signals (B) and anti-Clathrin positive signals (C) was assessed (n = 10) 6 
and 24 h after application of the MIX-NPs. D) MIX-NPs further co-localizing with Rab5, a marker for early 
endosomes. E) Both types of NP further show co-localization with LAMP2, a marker for lysosomes.  
 
A co-localization of 60% between positive signals of MIX-NPs and Rab5 (located on the cytoplasmic surface 
of early endosomes) confirms the involvement of clathrin dependent endocytotic pathways during the 
cellular internalization for both types of MIX NPs (Fig. 5, panel d). As early endosomes often ultimately fuse 
with lysosomes within the cell, we finally investigated the co-localization of nanoparticles and LAMP2 
(Lysosome-associated membrane protein 2), a marker for lysosomes. Images in Fig. 5, panel E clearly 
demonstrate the accumulation of MIX NPs in lysosomes. Indeed, both types of g7-(Rhod)-MIXs showed co-
localization with LAMP2 6 h after treatment. Co-localization decreases 24 h after treatment (Fig. 5 panel E). 
It might be possible that some nanoparticles escape from endo/lysosomes into the cytoplasm, or that the 
number of lysosomes increases as a consequence of the stress caused by treatment with g7 MIX NPs. 
Therefore, we quantified the amount of LAMP2 and RAB5 positive vesicles per cell in cultures treated with 
both g7-(Rhod)-MIX-N_a and g7-(Rhod)-MIX-SE_a. The results show that the total number of vesicles 
(lysosomes and RAB5 positive vesicles) is even decreased 24 h after application of MIX-NPs. Correlating this 
data with the number of MIX Nps per cells which remained constant, we can hypothesized that some MIX-
NPs may escape from lysosomes after 24 h of treatment (Fig. 6). 
 
 
 
Fig. 6: Co-localization of MIX NPs with LAMP2 and RAB5. The average number of LAMP2 positive structures 
(lysosomes) (A) and RAB5 positive structures (endosomes) (B) per cell was evaluated 6 and 14 h after 
treatment with MIX-NPs by immunocytochemistry and quantified for 10 cells per condition. 
 
4.2.3 Effect on excitatory synaptic receptors 
Assuming that Chol is incorporated into cellular membranes, possibly changing lipid composition, we next 
wondered whether we are able to detect alterations in the physiology of neurons. Given that synaptic 
  
 
18 
 
transmission is a key function of neuronal cells and that lipid composition might be especially important at 
excitatory postsynaptic spines, we focused on the characterization of alterations after MIX NPs application 
at these synapses in hippocampal neurons. Even in the early stages of HD, MRI and postmortem studies 
have shown that pathology is widespread with several structures affected, including the hippocampus, a 
region known to be important for learning, memory and spatial navigation (Bird and Burgess, 2008; Rosas 
et al., 2003). 
As proof of principle, we evaluated the composition of synaptic N-methyl-D-aspartate receptors (NMDAR) 
regarding the three major subunits (GluN1, GluN2A and GluN2B). NMDAR mediate synaptic plasticity and 
memory formation. After application of g7-MIX-N_a and g7-MIX-ES_a, an increase in GluN2B levels was 
observed after treatment (significant for g7-MIX-N_a, and as trend for g7-MIX-SE_a) (Fig. 7), along with a 
slight increase in GluN2A (significant for g7-MIX-SE_a). In turn, the synaptic levels of and GluN1 were 
significantly reduced after treatment with both types of MIX-NPs. Thus, the increase in GluN2A or N2B 
might not translate into an increase of functional receptors at the membrane, as functional NMDAR 
receptors will be formed of GluN1 together with either N2A or N2B. Nevertheless, this data shows that Chol 
was delivered by MIX NPs and was able to influence synapse composition by direct or indirect modes of 
action. 
 
 
Fig.7: Effect of g7-MIX NPs on excitatory synaptic receptors. g7-MIX NPs were applied to primary 
hippocampal neurons and NMDAR subunits quantified by Western Blot experiments. Experiments were 
performed in triplicates. A) Western blot band intensities were quantified for the three major subunits of the 
NMDAR, GluN1, N2A and N2B, and the values normalized against Actin. B) Exemplary images of Western 
Blot bands.  
 
5. DISCUSSION AND CONCLUSION:  
In this study, we proposed hybrid lipid-polymer nanoparticles (MIX NPs) as strategy to stabilize high 
amounts of Chol, and to optimize its administration and application in HD therapy. In MIX NPs, Chol 
assumes at once the role of active ingredient and integral part of the carrier so that the polymer composing 
NPs (PLGA) can be reduced.  
MIX NPs were formulated combining Chol and PLGA and by applying two easily up-scalable preparation 
techniques typically used in the rearrangement of hydrophobic materials, nanoprecipitation (MIX-N) and 
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single emulsion (MIX-SE). Unless is difficult to describe the internal structure of the nanometric systems, 
combining physical (dimension, surface charge), chemical (composition), morphological and stability 
studies, a different architecture of MIX NPs depending on the formulation technique can be proposed. 
Our working hypothesis is based on the premise that surfactant (type and concentration) as the production 
protocol play a pivotal role in the final structure. 
MIX-N was prepared applying the same method used in a previous study (Belletti et al., 2016) adding an 
acetonic solution of Chol/PLGA to a water dispersion of Pluronic F 68 (0.5% v/v at 45°C) reorganized in 
small micelles (Somasundaran, 2006; Tsui et al., 2008). As well described by Lannibois at al. (Lannibois et 
al., 1997) the competition between coalescence of hydrophobic material and adsorption of surfactants at 
the water–hydrophobic droplet interface governs the final size and the stability of nanoparticles formed 
during nanoprecipitation. We hypothesized that, the diffusion of acetone from the Chol-PLGA solution into 
the Pluronics micelles water phase induces the precipitation and the reorganization of all the three 
components – Chol, PLGA and Pluronics. Hence, Chol and PLGA are closely dispersed and Pluronic F68 could 
be solubilized into Chol for which it has a strong affinity (Maskarinec et al., 2002). The high residual amount 
of Pluronic F68 could justify the permeability of structure and the rapid release of Chol, with consequent 
destabilization of nanoparticles prevalently composed of Chol (see data on stability) the MIX-N_b, MIX-N_c 
and MIX-N_d (Chol:PLGA w/w ratio 1:0.4; 1:0.25; 1:0.1, respectively).  Only MIX-N_a appeared stable during 
time; the high amount of PLGA mixed in formulation (Chol:PLGA w/w ratio 1:1) probably well guarantees a 
better mixed system architecture.   
In MIX-SE preparation Pluronic F68 was replaced with PVA, a water dispersible polymer typically used to 
stabilize the emulsion (Dinarvand et al., 2011). The slow solvent evaporation induces the precipitation of 
the two major component PLGA and Chol according to the solubility or/and to the precipitation rate. 
Hence, the component cannot be closely dispersed. Therefore, the nanoparticle structure could be formed 
by a non-homogeneous core of Chol and PLGA regardless to the ratio of the two components surrounded 
by a PVA layer (Sahoo et al., 2002).  
Independently from the preparation approaches (nanoprecipitation and single emulsion), Chol:PLGA ratio 
of 1:1 w:w was the most suitable composition whit respect to chemical physical composition, final Chol 
content, stability and yield of production, thus this sample was selected for further investigations. 
Aiming to transport Chol into the brain, we engineered the surface of MIX NPs with g7, a peptide designed 
for BBB crossing. g7-MIX-N_a obtained by nanoprecipitation and g7-MIX-SE_a obtained by single emulsion, 
were tested in vitro using hippocampal cells. From a toxicological point of view, we did not observe enough 
cellular stress caused by MIXs to induce apoptotic pathways in cells or cause necrosis of cells. However, g7-
MIX-N_a NPs, in which the sterol is probably more accessible and un-protected, slightly induced more 
cleavage of caspase-3 compared to g7-MIX-SE_a.  
Interestingly, both samples followed the same pathway for cellular uptake, taking advantage mainly of 
clathrin-dependent mechanism. These findings strongly agree with previous published data describing the 
cellular interaction of g7-NP made only by PLGA (Vilella et al., 2015), suggesting that the presence of the 
targeting g7 than the surface composition (Chol-PLGA ratio) has a major effect on the nanoparticles-cell 
interaction. Moreover, both g7-MIX NPs showed the ability to escape from lysosomes to some extent, 
making Chol available for biological functions. 
We then wanted to investigate if the different MIX-NPs reorganization was able to affect the cellular 
response focusing on NMDAR expression which is involved in the initial neuronal stress and dysfunction.    
In fact, NMDAR-mediated excitotoxicity has been proposed to play a role HD and increased striatal NMDAR-
mediated synaptic currents in YAC72, a mouse model for HD, compared to wild-type mice were reported (Li 
et al., 2003). 
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We observed that g7_MIX NPs induced some alterations in NMDAR which highlights effects of the delivered 
NPs at intracellular level, however, we detected slight differences in between the two types of g7 MIX-NPs 
on NMDAR composition, which confirmed that the different “architecture” may reflect minor differences in 
cellular interaction, even if it could influence the kinetic of drug-release. Based on this hypothesis, g7-MIX-
SE NPs in which Chol should be more segregated into nanoparticles and released slowly, could be more 
useful for the modulation of the synaptic transmission in HD model.  
This study through a combinatory approach that put together information from formulation, chemical 
physical characterization and in vitro test described a novel concept of “precision nanomedicine” 
specifically designed holding to mind the biological features of the pathology, relocating this concept from 
tumor to brain diseases. Chol that is deficient in HD brain was used not as a “simple active to encapsulate” 
but as a component of MIX–NPs targeted to the brain offering a unique non-invasive therapeutic option for 
restoring brain Chol deficiency.  Further investigation in HD animal model will clarify the efficacy and the 
performance of this two kind of NPs opening the pave for innovative, intelligent treatment of HD. 
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TableS1: Schematic representation of the samples formulated 
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NP-N physico-chemical/technological 
characterization 
1:1 25 25   MIX-N_a physico-chemical/technological 
characterization 
1:1 25 22.5 2.5  g7-MIX-N_a In vitro study (toxicity) 
1:1 25 21.3 2.5 1.2 g7-(Rhod-)MIX-N_a In vitro study (uptake) 
1:0.4 35.5 15.5   MIX-N_b physico-chemical/technological 
characterization 
1:0.25 40 10   MIX-N_c physico-chemical/technological 
characterization 
1:0.1 45 5   MIX-N_d physico-chemical/technological 
characterization 
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NP-SE physico-chemical/technological 
characterization 
1:1 25 25   MIX- SE _a physico-chemical/technological 
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1:1 25 22.5 2.5  g7-MIX-SE_a In vitro study (toxicity) 
1:1 25 21.3 2.5 1.2 g7-(Rhod)-MIX-SE 
_a 
In vitro study (uptake) 
  
 
24 
 
 
FIG S1: DSC analyses 
 
 
 
Data of DSC of plane components, physical mixtures and samples. Data in table refer to the first heating 
cycle and  to the second re-heating that occurs after a controlled cooling. For each run onset and related 
area of transition were reported; in the histograms we reported analyses of the decreasing of enthalpy 
associated with Chol melting after first eating and cooling cycle 
 
 
Tonset (°C) 
[S.D]
Area (J/g)  
[S.D]
Tonset (°C) 
[S.D]
Area (J/g)  
[S.D]
Tonset (°C) 
[S.D] Area (J/g)  [S.D]
first 47.2  [2.1] 15.2 [0.5]
second 45.0 [1.2] 13.9 [0.4]
first 38.1 [1.1] 6.8 [0.9] 151.0 [2.1] 47.0 [0.5]
second 150.0 [1.5] 47.2 [0.4]
first 31.7 [1.2] 4.9 [0.8]
second
first 51.2 [1.0] 81.0 [1.0]
second 50.1 [0.9] 70.9[0.4]
first 31.2 [1.2] 6.1 [1.1] 144.1 [0.8] 46.9 [1.2]
second 35.5 [0.3] 2.7 [0.4] 143.0 [0.8] 51.6 [1.2]
first 31.2 [0.7] 4.9 [0.9] 144.2 [1.5] 46.9 [0.5]
second 37.9 [0.8] 3.7 [1.2] 143.8 [1.2] 46.8 [0,7]
first 36.2 [1.2] 0.7 [1.2] 40.8 [0.5] 1.2 [0.7] 145.3 [1.8] 41.0 [1,0]
second  37.3 [1.8] 0.7 [0.3] 137.2 [0.3] 27.9 [1.1]
first 36.1 [0.7] 1.7 [0.5] 43.6 [1.1] 3.6 [0.5] 147.6 [1.5] 32.1 [0.8]
second 37.2 [0.5] 0.8 [0.5] 142.8 [1.2 22.1 [0.9]
first 36.0 [1.0] 0.6 [0.1] 43.1 [0.9] 2.6 [0.4] 147.6 [1.2] 16.2 [0.7]
second 37.4 [0.3] 0.8 [0.1] 126.4 [0.4] 8.4 [0.3]
first 36.2 [1.2] 0.1 42.9 [0.6] 4.5 [0.5] 146.9 [1.1] 3.7 [0.3]
second 36.1 [0.4] 1.1 [0,2]
first 142.9 [1,1] 20.8 [0.6]
second 30.6 [0.2] 1.8 [0.2] 48.7 [0.7] 11.4 [0.8] 142.5 [1.2] 19.5 [0.4]
first 144.7 [1.3] 31.5 [0.5]
second 29.7 [0.7] 1.8 [0.5] 45.6 [0.5] 10.7 [0.5] 142.3 [0.5] 29.7 [0.9]
first 48.9 [1.2] 3.7 [0.3] 147.5 [0.5] 24.6 [0.9]
second 141.2 [1.9] 19.8 [0.4]
first 46.2 [0.7] 5.4 [0.2] 147.6 [1.4] 26.6 [1.2]
second 144.7 [1.8] 22.2[0.5]
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FIG S2: size distribution  
 
 
Table S2: Chol content in MIX-N_a and MIX-ES_a after incubation in PBS added of FBS (50% v/v) at 37°C. 
After incubation, samples were purified by centrifugation and nanoparticles analyzed for the Chol content 
as reported in methods section. 
 
 
 
 
 
 
Table S3: Physico-chemico characterization of modified samples used for in vitro study 
 
Sample Z-Ave 
(±SD) 
[nm] 
PDI 
(±SD) 
D90 
(±SD) 
[nm] 
Z-Pot 
(±SD) 
% 
Chol  
% 
PLGA 
% 
surfactant. 
g7-MIX-N_a 235       
(±9) 
0,26       
(±0,02) 
518       
(±33) 
-25 
 (±3) 
33                     
(±11) 
55                    
(±9) 
12           
 (±2) 
g7-(rhod)MIX-N_a 225           
(±11) 
0,22       
(±0,03) 
505        
(±24) 
-21 
 (±2) 
34                       
(±4) 
56                       
(±7) 
8                              
(±1) 
g7-MIX-SE_a 278       
(±15) 
0,16       
(±0,01) 
471        
(±14) 
-23 
 (±4) 
45                       
(±3) 
51                      
(±4) 
4      
 (±1) 
Sample Content of Chol 
(%) T0 
Content of Chol (%) 
T 6h 
MIX-N_a 38 ± 5 32± 3 
MIX-ES_a 44 ± 2 41 ± 5 
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g7-(rhod)MIX-SE_a 2911           
(±21) 
0,19       
(±0,03) 
489       
(±18) 
-20 
 (±1) 
43                     
(±2) 
54                    
(±2) 
3           
   (±1) 
 
 
 
 
 
 
 
 
 
FIG. S3: ESCA analyses 
 
  
The presence of g7 on NPs surface was demonstrated by electron spectroscopy for chemical analysis 
(ESCA), showing the presence of nitrogen atoms on the surface of engineered NPs. ESCA was performed on 
a XRC 1000 X-ray source analysis system (Specs Surface Nano Analysis, Germany) and a Phoibos 150 
hemispherical electron analyzer (Specs Surface Nano Analysis, Germany), using MgKα1,2 radiations. 
Spectra were recorded in fixed retardation ratio (FAT) mode with 40 eV pass energy. The pressure in the 
sample analysis chamber was around 10−9 mbar. Data were acquired and processed using the SpecsLab2 
software. 
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